Position Statements

Guidelines

Here you will find our prescribing guidelines including shared care guidelines and patient information leaflets.

To see which CCGs have adopted the guidance please download the document below:

Name	Size	Hits
Biological Agents For Treating JIA In Adult Patients (Version 2.0)	208.7 KiB	808
Biosimilars of Etanercept (Version 1.0)	268.5 KiB	620
Biosimilars of Infliximab (Version 1.1)	271.7 KiB	1835
Camouflage Products Position Statement (Version 1.1)	166.3 KiB	5
Cannabis Based Medicinal Products For Pain (Version 1.0)	464.8 KiB	305
Choice of direct-acting oral anticoagulant (DOAC) for stroke prevention in atrial fibrillation (AF) (Version 1.2)	213.3 KiB	602
Denosumab Position Statement (Version 1.0)	291.3 KiB	701
E‑Cigarettes Position Statement (Version 2.0)	162.8 KiB	951
Empagliflozin Position Statement (Version 1.0)	577.8 KiB	1118
Fentanyl & Buprenorphine Patches For Pain (Version 1.0)	332.4 KiB	45080
Generic Biosimilar Position Statement (Version 1.0)	218.0 KiB	749
Melatonin Position Statement (Version 1.2)	615.1 KiB	901
Nutritional Supplements Post Bariatric Surgery (version 1.1)	281.4 KiB	7509
Out Of Area Prescribing Position Statement (Version 1.0)	166.1 KiB	170
PKU (Phlexy-Vit) Position Statement (Version 1.0)	664.8 KiB	408
Trans-Anal Irrigation Devices Position Statement (version 1.2)	230.4 KiB	1720
Vitamin D Position Statement (Version 3.0)	195.7 KiB	4054
Vitamins And Minerals (Version 1.2)	295.0 KiB	1440